MedPath

Ebola Vaccine Ring Vaccination Trial in Guinea

Not Applicable
Conditions
Ebola Virus Disease
Registration Number
PACTR201503001057193
Lead Sponsor
World Health Organization
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
21500
Inclusion Criteria

Individuals aged 18 years or older who live in the defined vaccination ring

Children 6 to 17 years following results from phase 2 study in Gabon, and following DSMB recommendation (3 July 2015)

Exclusion Criteria

History of EVD (self-report or laboratory confirmed).
Pregnancy (verbal report) or breast-feeding. Women will be offered, but not required to take, a pregnancy test.
History of having received other investigational research agents in the previous 28 days.
Self- report of clinically important immunodeficiency condition, e.g. HIV/AIDS.
History of anaphylaxis to a vaccine or vaccine component
Severe illness that makes the person bed-bound or requiring hospitalization at the time of the vaccination.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Any probable or supsected case from which a blood sample taken is laboratory confirmed as positive for EVD, or any deceased individual with probable EVD, from which a post-mortem sample taken within 48 hours after death is laboratory confirmed as positive for Ebola Virus Disease
Secondary Outcome Measures
NameTimeMethod
Incidense of Serious Adverse Events
© Copyright 2025. All Rights Reserved by MedPath